Cefuroxime Axetil and Potassium Clavulanate (ZYDUS)

Cefuroxime Axetil and Potassium Clavulanate tablets deliver a powerful dual-action antibiotic therapy that treats a wide range of bacterial infections with precision and speed. This combination works by actively stopping bacterial growth and blocking resistance mechanisms, which helps the body eliminate infection more effectively. Doctors prescribe this medicine to manage respiratory tract infections, sinusitis, bronchitis, urinary tract infections, skin infections, and ear infections.

This formulation combines a second-generation cephalosporin antibiotic with a beta-lactamase inhibitor to enhance antibacterial activity. Cefuroxime Axetil directly attacks bacteria by disrupting their cell wall synthesis, which causes bacterial death. Potassium Clavulanate protects the antibiotic from enzymatic breakdown, which ensures consistent performance against resistant bacterial strains. Together, they create a strong and reliable treatment option.

Patients benefit from faster symptom relief, reduced infection severity, and improved recovery outcomes when they follow the prescribed dosage correctly. This medicine supports targeted infection control and minimizes the risk of complications when used under medical supervision. Healthcare professionals trust this combination for its proven effectiveness and broad-spectrum coverage.

Users should take the tablets exactly as directed by their doctor to achieve optimal results. They should complete the full course to prevent bacterial resistance and recurrence of infection. Patients should also maintain proper hydration and follow medical advice during treatment.

Zydus manufactures this product under strict quality standards, which ensures safety, consistency, and therapeutic effectiveness. This antibiotic combination provides a dependable solution for managing bacterial infections and restoring health efficiently.